Intelligence Report
For patients who need a complete picture of what exists globally for their specific case — across approved therapies, off-label options, active clinical trials, and investigational agents in development.
This is not a database query. It is a structured research engagement: we analyze your molecular profile, disease stage, and treatment history, then systematically map every viable pathway we can identify across global registries, regulatory filings, and scientific literature.
The output is a written intelligence brief designed to be handed directly to your oncologist or specialist — structured, sourced, and actionable.
Request This ReportWhat's included
Approved therapy mapping
FDA, EMA, and international approvals matched to your molecular subtype and disease stage
Global clinical trial matching
Active trials across ClinicalTrials.gov, EU CTR, WHO ICTRP, and registries beyond Western databases — with eligibility pre-screening against your profile
Off-label & investigational options
Evidence-supported off-label use cases and late-stage pipeline molecules that may be accessible via expanded access or compassionate use
Specialist & center identification
Most relevant specialists and centers worldwide for your specific diagnosis — structured for outreach
One follow-up clarification session
A 30-minute call after delivery to walk through findings and answer your questions
What's included
Initial Intelligence Report
Full baseline report delivered in the first week — approved therapies, trials, off-label options, and investigational agents matched to your profile
Minimum 4 updates per month
Regular briefings covering new trial openings, regulatory decisions, pipeline developments, and any changes relevant to your case
Trial enrollment facilitation
Active support in contacting trial sites, preparing case summaries for eligibility review, and navigating enrollment logistics
24-hour priority response
Urgent questions answered within 24 hours — for time-sensitive decisions around treatment changes or trial deadlines
Cancel anytime — no lock-in
Month-to-month commitment. Cancel or pause at any time with no penalty
Best for: Patients currently in treatment, on a trial waitlist, or navigating a rapidly evolving diagnosis where the intelligence landscape changes week to week.
Monthly Retainer
A single report captures a moment in time. But for patients in active treatment, the landscape shifts constantly — new trials open, drugs receive accelerated approvals, compassionate use windows appear and close.
The Monthly Retainer is designed for cases that need continuous intelligence coverage — not a one-time snapshot. We monitor the full landscape around your diagnosis on an ongoing basis, flagging anything that becomes relevant as it emerges.
This is the closest thing to having a dedicated medical intelligence analyst working your case every week — without the cost of a full-time researcher.
Start Monthly PartnershipExpert Consultation
Sometimes you don't need a full research engagement — you need 60 minutes with someone who can read your NGS report fluently, explain what your biomarkers actually mean for treatment options, and help you prepare the right questions before a critical specialist appointment.
The Expert Consultation is a focused, one-on-one session built around your specific documents and situation. We work through whatever is most pressing — a confusing genomic result, a treatment decision you're weighing, or a second look at a care plan that doesn't feel complete.
A written summary of key points and next steps is delivered after every session.
Book a SessionCommon use cases
NGS / genomic report walkthrough
You received a next-generation sequencing report and want to understand what the mutations, variants, and biomarkers actually mean for your treatment options
Treatment plan second look
Your current plan doesn't feel complete or you want a second perspective on whether there are options your care team may not have considered
Pre-appointment preparation
You have a key specialist appointment coming up and want to walk in with the right questions, the right framing, and a clear picture of what to push for
Rare disease diagnostic review
A complex or unresolved diagnosis where you want expert eyes on the workup, the differential, and whether alternative diagnostic pathways have been exhausted
Session format
Before You Submit
What to prepare
The more detail you provide, the more targeted the research. Share what you have — even partial information is a starting point.
Essential — bring these
Required to begin the research
Primary diagnosis
Confirmed diagnosis with ICD code if available, disease stage, and histological subtype
Treatment history
All prior treatments, lines of therapy, and response or resistance outcomes
Current treatment status
What you are on now, performance status, and any contraindications
What you are looking for
Clinical trials, approved options, off-label agents, second opinion support — or all of the above
Helpful — share if available
Significantly improves research depth
NGS / genomic sequencing report
Foundation Medicine, Tempus, Novogene, or any panel — enables molecular-level trial and therapy matching
Pathology & biopsy reports
Histopathology findings, IHC markers, tumor mutational burden, MSI status
Imaging & staging reports
Recent CT, PET, MRI reports with radiologist notes on disease extent
Prior specialist opinions
Second opinion letters, tumor board summaries, or multidisciplinary team notes
Don't have everything on this list — submit anyway. The free intake call is the right place to discuss what you have and what the research can realistically cover.
Is this a substitute for seeing a doctor?
No — and it is not designed to be. EviGeno provides structured intelligence research: a map of what treatment options exist for your case globally. The report goes to your care team, who make the clinical decisions. We work alongside your doctors, not instead of them.
What makes this different from searching ClinicalTrials.gov myself?
ClinicalTrials.gov is one registry covering US-registered trials. A significant portion of relevant trials — particularly in rare disease and oncology — are registered only in European, Asian, or country-specific registries that do not appear there. Beyond trials, an Intelligence Report also covers approved therapies matched to your molecular subtype, off-label options supported by literature, investigational agents accessible through expanded access, and specialist identification. The breadth and depth of what we cover cannot be replicated by a single search.
Do I need to have an NGS / genomic report?
No. A genomic report significantly expands what we can match — particularly for targeted therapy and biomarker-driven trial eligibility — but it is not required. We can conduct a meaningful research engagement based on diagnosis, staging, histology, and treatment history alone. If you don't have an NGS report, we can also advise on whether testing would be worthwhile for your case.
How is my medical information handled?
All case information is held in strict confidence and used solely for the purpose of your research engagement. EviGeno does not share, sell, or disclose patient information to any third party. Documents are handled securely and retained only as long as needed to deliver and support your engagement.
What if my case is very rare or complex?
Complex and rare cases are exactly what EviGeno is designed for. Standard searches fail most severely on uncommon diagnoses — the rarer the condition, the more likely that relevant options are scattered across obscure registries, niche literature, and non-English regulatory filings. These are the cases where deep, manual research makes the biggest difference. If your case is unusually complex, we will discuss scope and timeline transparently on the intake call.
Can I upgrade from a single report to the monthly retainer?
Yes. Many clients start with a single Intelligence Report to understand the landscape, then move to the monthly retainer once they are actively pursuing a trial or navigating an evolving treatment situation. The transition is seamless — your existing case file carries forward with no duplication of work.
Get Started
Your case deserves
a complete picture.
Start with a free 20-minute intake call. No payment, no commitment — just a conversation to understand your case and confirm we can help.
We respond within 24 hours
Every inquiry is reviewed personally — no automated responses
Free 20-min intake call before any payment
We confirm fit before you commit to anything
Report delivered in 5–7 business days
Scope and timeline confirmed upfront for complex cases
Or reach out directly
[email protected]Submit your case
We'll review your situation and be in touch within 24 hours.